DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the activation of its first U.S. clinical trial site to evaluate PBGENE-HBV as part of the ELIMINATE-B Phase 1 clinical trial. The newly activated site at Massachusetts General Hospital in Boston, Massachusetts, is now actively recruiting patients. ". ...

CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on October 1, 2025, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment. The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 65,200 shares of Intellia’s common stoc ...

Can we make a real life Jurassic Park. I know that my title sounds flashy and improbable. However, there have been new studies that deem that it may be possible.Extinction has caused the biodiversity of our world to drop massively. And scientists say that the biodiversity of the world may drop by 27% in vertebrates by 2050. This is devastating as I'm aware all of you know.However, this is not what I'm here to talk about. An institute in the United States named Colossal Laboratories and Biosciences, which I' ...

ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress, taking place October 7-10, 2025. The presentation will introduce the Company’s novel SyNTase gene editing technology and highlight its application in single-dos ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced a late-breaking poster presentation at the 30th Annual International Congress of the World Muscle Society (WMS) being held October 7-12, 2025, in Vienna, Austria. "We look forward to sharing the latest preclinical data for PBGENE-DMD at the upcoming. ...

Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmersSAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to ...

One dose of nex-z led to rapid, deep and durable TTR reductions, with mean reductions of at least 90% from baseline sustained through three yearsStabilization or improvement in disease-related clinical measures observed at 24 monthsContinue to observe generally favorable safety data with no new drug-related events within the follow-up periodData presented today at the 5th International ATTR Amyloidosis Annual Meeting for Patients and Doctors with simultaneous publication in the New England Journal of Medici ...

[μουσική] [χειροκρότημα] [χειροκρότημα] Καλησπέρα σας. Έχετε κάνει ποτέ μια εξέταση και φοβηθήκατε να δείτε το αποτέλεσμα Μπορεί να ήτανε κάτι απλό, μια γενική αίματος ή κάτι λίγο πιο σοβαρό, μια μικρή βιοψία. Εκείνη στιγμή που ο φόβος να μάθεις ξεπερνάει την ανάγκη να ξέρεις.Τώρα φανταστείτε πως η εξέταση αυτή δεν αφορά το παρόν, αλλά το μέλλον σας. Πώς θα νιώθατε αν ξέρετε ότι έχετε για παράδειγμα 60% αυξημένο κίνδυνο να εμφανίσετε καρδιακιακή νόσο ή 40% μεγαλύτερη πιθανότητα για αλzχάμε στα 58 σας θα θέλ ...

I want you guys to all first picture yourselves walking into a salon here. Instead of choosing a new hairstyle, you're choosing new jeans. Would you buy an enhanced memory gene pack that has a coupon for Ivy students.Perhaps a perfect athleticism combo. The case where we can edit our genes easily is a future that we are quickly approaching. And with these emergent technologies, we are facing questions that no challenges before have ever had to answer.Today, I'm not here to assert whether genetic editing is ...

اللي تشوفونه شريحه فيها 7 مليون روبوت نانو ما نقدر نشوفها بالعين المجرده كي ولكن في كل واحد فيكم يمشي في دمه ملايين الروبوتات اليوم ويمكن اغلبكم ما يدري كيف راح اقول لكم بعدين ولكن اتمنى في نهايه اليوم انه تكونوا مستعدين للتحديث الجديد [تصفيق] كليكر ورك اوكي جود روبوتات النانو مو شيء بسيط ابدا شيء جدا اقل من تصميمه لانه في الاساس يشتغل على مستوى الذرات ومستوى الجينات يحتاج ل خبرات كبيره يحتاج لعلوم كبيره لتصميمها الجميل في في روبوتات النمو انها ممكن تدخل جسم الانسان وممكن تسبح بين خلايانك وممكن ممكن توصل لا ...